Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

17β-estradiol can reduce inflammation in the skin.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Blocking JAK-STAT signaling can lead to hair growth.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Balancing testosterone may reduce COVID-19 severity.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Targeting the actin cytoskeleton could improve skin healing and reduce scarring.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

The study was retracted.